Navigation Links
Synvista Therapeutics Appoints William Federici to its Board of Directors
Date:10/10/2008

ople with diabetes. The Company has developed a clinical diagnostic test for Hp2-2 Diabetes, a disease affecting almost 7 million patients in the United States. The genetic or protein form of this test can be used to identify diabetic patients at high risk for cardiovascular complications. These patients may benefit from a particular formulation of vitamin E. The Company is also developing a kit to measure CML (carboxy-methyllysine), another potential cardiovascular risk marker.

Synvista Therapeutics is developing oral antioxidant drugs to treat the HDL dysfunction seen in Hp2-2 Diabetes. The Company is also developing alagebrium, a proposed breaker of advanced glycation endproducts (AGEs) for the treatment of systolic and diastolic heart failure. Diastolic heart failure represents a rapidly growing market of unmet medical need, particularly common among diabetic patients. Alagebrium has demonstrated relevant clinical activity in two Phase 2 clinical trials in heart failure, as well as in animal models of heart failure and nephropathy, among others. Alagebrium has been tested in approximately 1,000 patients in multiple Phase 1 and Phase 2 clinical trials, allowing Synvista Therapeutics to assemble a sizeable human safety database.

For more information, please visit the Company's Web site at http://www.synvista.com.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the events described in this press release, future clinical development of Synvista Therapeutics' diagnostic tests and product candidates, and other risks identified in Synvista Therapeutics' filings with the Securities and Exchange Commission. Further information on risks faced by Synvista are detailed under the caption "Risk Factors" in Synvista Therapeutics' Ann
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference
2. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster
4. Cell Therapeutics Regains Compliance with NASDAQs Minimum Bid Price Requirement
5. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes
6. Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
7. Afid Therapeutics Inc.s New Anticoagulant Heparin Replacement Passes in Vivo Test
8. Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues
9. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
10. TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results
11. Clinical Research Management gets contract for trials of therapeutics against infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, 2014 ... raise your risk for high blood pressure, a new study ... lived within 109 yards of a busy road had a ... women living at least half a mile away, researchers report. ... of our physical environment on our health and well-being," said ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... that pull out all the stops to rescue surgical ... but the cost of such heroism is questionable, a ... 5 percent better at saving elderly patients with life-threatening ... with less intensity, said senior author Dr. Amir Ghaferi. ...
(Date:10/1/2014)... Psychiatry researchers from the University of Adelaide have developed ... likelihood of a good outcome from treatment - from ... based on a range of factors, including clinical symptoms, ... biomarkers in the patient,s blood. , Speaking in the ... the University,s Head of Psychiatry , Professor ...
(Date:10/1/2014)... Journal of the American Medical Association shows ... or severe chronic knee pain, acupuncture did not provide ... randomly assigned 282 patients (50 years or older) with ... pretend laser treatment. , Treatments were delivered for ... and sham (inactive) laser acupuncture. , Researcher Professor Kim ...
(Date:10/1/2014)... 2014 Patients with increased inflammation, including those ... increased risk of depression. For example, a 6-month ... C virus infection causes depression in approximately 30% ... commonly known as fish oil, have a long ... of heart disease and reducing triglyceride levels. These ...
Breaking Medicine News(10 mins):Health News:Living Near a Highway May Be Bad for Your Blood Pressure 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 3Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Predicting the future course of psychotic illness 2Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:Omega-3 fatty acids may prevent some forms of depression 2
... ... products LLC. has announced that they have added a new line ... Supplements and Vitamins are produced on FDA registered and inspected facility ... All Alternative Medicine’s Nutritional vitamins and supplements make them safe, top ...
... , , SILVER ... Administration is warning the public about criminals posing as FDA ... an international extortion scam. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... in most cases previously purchased drugs over the Internet or ...
... , , , ... a key part of the country,s social contract and want to ... significant changes in the program to hold down its costs as ... from all walks of life considered the pros and cons of ...
... , LOS ANGELES, Dec. 29 The Criminal Defense ... premier Los Angeles Fraud Defense Firm, have successfully represented numerous ... allegations of Medi-Cal and Medi-Care theft. , The ... who are facing state and federal criminal fraud charges, as ...
... , CHICAGO, Dec. 29 Earlier this month, leaders ... forces under the Comprehensive Obesity Recovery Effort (CORE, LLC). Insight ... have formed CORE to help people lose weight. , According ... of calorie intake vs. calorie expenditures. What ...
... To keep sneezing and wheezing at bay, follow these expert ... can bring some relief to those allergic to mold and ... itchy eyes and wheezing for asthma and allergy sufferers. , ... mites, pet dander, cigarette smoke, gas fumes and household sprays ...
Cached Medicine News:Health News:All Alternative Medicine Products LLC. Presents a New Line of Natural Nutritional Supplements and Vitamins 2Health News:All Alternative Medicine Products LLC. Presents a New Line of Natural Nutritional Supplements and Vitamins 3Health News:All Alternative Medicine Products LLC. Presents a New Line of Natural Nutritional Supplements and Vitamins 4Health News:FDA Warns Public of Continued Extortion Scam by FDA Impersonators 2Health News:New Study Shows That American Public is Willing to Accept Major Reforms in Medicare Program 2Health News:New Study Shows That American Public is Willing to Accept Major Reforms in Medicare Program 3Health News:New Study Shows That American Public is Willing to Accept Major Reforms in Medicare Program 4Health News:Los Angeles Healthcare Fraud Defense Lawyers Announce Recent Results in California Medi-Cal and Medi-Care Criminal Law Cases 2Health News:Los Angeles Healthcare Fraud Defense Lawyers Announce Recent Results in California Medi-Cal and Medi-Care Criminal Law Cases 3Health News:Chicago's CORE Uses Medicine and the Mind for Weight Loss 2Health News: Indoor Allergies Common in Winter 2
(Date:10/2/2014)...   West Pharmaceutical Services, Inc. (NYSE: ... for injectable drug administration, announced today it plans to ... site in Waterford, Ireland . The ... cartridges and other high-value packaging components, in order to ... operational, this new site could bring approximately 150 new ...
(Date:10/1/2014)... Oct. 1, 2014 The Cardinal ... Interested parties can learn about the company,s ... is supporting the health care continuum by ... Photo- http://photos.prnewswire.com/prnh/20140930/149504-INFO ... and the chief executive officer,s letter to ...
(Date:10/1/2014)... SAN DIEGO , Oct. 1, 2014  ResMed (NYSE: ... people sleep and the first company to design complete sleep ... to educate women about the importance of a good night,s ... initiative will challenge the myth that feeling tired is just ... to understand that sleep is a critical pillar of health, ...
Breaking Medicine Technology:West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 2West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 3West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 4West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 5Cardinal Health 2014 Digital Report to Shareholders Now Available 2ResMed Launches Initiative to Help Women Get Better Sleep 2ResMed Launches Initiative to Help Women Get Better Sleep 3
... , SAN DIEGO, Nov. 25 NuVasive, Inc. (Nasdaq: ... for minimally disruptive surgical treatments for the spine, announced today that ... at 5:30 p.m. ET / 2:30 p.m. PT. The conference ... Company,s products and will include comments from management followed by a ...
... ... a new market research report is available in its ... Trends & Analysis http://www.reportlinker.com/p0164267/Intranasal-Drug-Delivery---US-Market-Trends--Analysis.html , The ... of therapeutic applications from the delivery of conventional local ...
Cached Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5
The ApexPro CH is operational within the WMTS. It offers operating performance, up to 240 WMTS channels, and up to 120 hours of battery life....
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
... the ISI Lexan Universal K ... table for lower and upper ... and neck, and lower extremity ... package gives you the ability ...
... Our manufacturing process ... flux-density nanocrystals ensuring magnetic ... allied with the rigid ... no magnetic aggregation occurs ...
Medicine Products: